Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis

NCT05739435 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
165
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Alumis Inc